Pharmaceutical (6)

Jonathan Roses was quoted by Bloomberg Law in an article titled “PTAB Sees Fewer Drug Patent Fights as Generics’ Strategy Shifts.” Read more.

Wolf Greenfield is pleased to announce the promotion of seven attorneys to the position of shareholder, effective January 1, 2021, marking the most shareholder elevations made at one time in the firm’...

Andrew Williams was quoted by IAM in an article titled “Stricter Criteria Will Now Apply to Venue Selection in ANDA Patent Disputes.” Read more (subscription required).

Wolf Greenfield received the top ranking of “highly recommended” for both patent prosecution and patent strategy and management in the 2020 edition of LMG Life Sciences. Clients noted: “Their level of...

Rob Sahr was quoted by Managing IP in an article titled “Pharma fears corruption of ‘hugely successful’ Bayh-Dole Act.” Read more (subscription required). This article comes off the heels of a panel R...

Twenty-nine Wolf Greenfield attorneys were selected by their peers for inclusion in The Best Lawyers in America® 2021. Members of every practice group at the firm were represented. Twenty-one were nam...

Wolf Greenfield is a finalist for “Patent Strategy Firm of the Year” at the LMG Life Sciences Awards 2020. In addition, Oona Johnstone, a shareholder in the firm’s Biotechnology Practice, is a finalis...

Wolf Greenfield has once again been recognized by Managing IP. The firm was ranked nationally for: Life Sciences IP PTAB Litigation In addition, the firm was ranked in all three categories—patent cont...

Wolf Greenfield has once again been recognized by the IAM Patent 1000: The World’s Leading Patent Professionals. The firm was ranked nationally for prosecution. Rich Giunta, chair of the firm's Post-G...

In an interview with American Healthcare Leader, Ed Gates shares his journey to becoming an IP lawyer and how the firm has grown since joining in 1984. Read the full interview here.

Heather DiPietrantonio was quoted by Bloomberg Law in article titled “Regeneron Hybrid Mouse Patents Called Invalid By Top UK Court.” Read more (subscription required).

Dan Young was quoted by Law360 in an article titled “Pandemic Collaborations Pose Risk Of Future Patent Disputes.” Read more (subscription required).